Clinical Trials Browser

INDUSTRY × Drug Evaluation × Breast × Clear all

NCT05054751 2024-10-10

GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT03236974 2020-02-06

D6090C00002

Phase 1 Completed

Postmenopausal Women With ER+ HER2- Primary Breast Cancer